Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Revance Therapeutics (RVNC)
Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeutics, Inc. - RVNC

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC). Such...

RVNC : 7.14 (+26.15%)
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates

Revance Therapeutics, Inc. (RVNC) delivered earnings and revenue surprises of 1.33% and 8.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RVNC : 7.14 (+26.15%)
TMBR : 0.3426 (+0.74%)
Top 4 Stocks Set to Beat on Earnings Today After Market Closes

We have narrowed our search to four stocks that are set to report earnings results today after market closes. These are: WYNN, CELH, RVNC and IAC.

WYNN : 105.20 (+2.27%)
RVNC : 7.14 (+26.15%)
IAC : 56.80 (+1.52%)
CELH : 81.62 (+20.44%)
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Misses Revenue Estimates

Omega Therapeutics, Inc. (OMGA) delivered earnings and revenue surprises of 21.88% and 31.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

OMGA : 4.11 (+0.74%)
RVNC : 7.14 (+26.15%)
Revance to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Revance Therapeutics, Inc. (RVNC), today announced that the company will release first quarter 2023 financial results on Tuesday, May 9, 2023, after the close of market. Revance will host a corresponding...

RVNC : 7.14 (+26.15%)
Revance to Participate in the Needham 22nd Annual Healthcare Conference

Revance Therapeutics, Inc. (Nasdaq: RVNC), today announced that the company will participate in the 22 nd Annual Needham Virtual Healthcare Conference, taking place April 17 – 20, 2023. Chief Financial...

RVNC : 7.14 (+26.15%)
Revance Publishes its 2022 Environmental, Social, and Governance (ESG) Report

Revance Therapeutics, Inc. (RVNC), today announced the release of its 2022 ESG Report, detailing the company’s progress towards its ESG priorities of innovation and access, workplace culture and strong...

RVNC : 7.14 (+26.15%)
Intra-Cellular (ITCI) Surges 16.4%: Is This an Indication of Further Gains?

Intra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

ITCI : 69.52 (-2.26%)
RVNC : 7.14 (+26.15%)
Revance to Participate in Upcoming Investor Conferences

Revance Therapeutics, Inc. (RVNC), today announced that the company will participate in the following investor conferences.

RVNC : 7.14 (+26.15%)
Wall Street Sees 23% Upside In Revance, Maker Of Botox Competitor

Revance Therapeutics gapped up 54.34% on January 9, and built upon those gains in February. The company reported its first revenue for Botox competitor Daxxify.

RVNC : 7.14 (+26.15%)
ABBV : 176.05 (-1.10%)

Barchart Exclusives

US Crude Oil Inventories Surge Beyond Expectations: How Will This Impact the Seasonal Buy?
Since mid-December, when the crude oil futures made a seasonal low, the market has steadily traded higher. A typical seasonal pattern usually sees crude oil bottoming in December or January before rallying into May 01. But what if you missed the first leg of this uptrend? Is there an upcoming opportunity that may offer a chance to buy crude oil? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar